Company Name:Nektar Therapeutics
CEO: Howard W. Robin

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Nektar Therapeutics Inc is a biopharmaceutical company engaged in the development of new molecules to treat diseases with unmet medical needs. The company is researching and developing drugs for treating cancer, auto-immune disease and chronic pain.


Key numbers

Market Capitalization:3954726560
Shares Outstanding: 175922000
Float: 173381159
Next Earning Date:2020-02-25
TTm EPS: -2.4415
TTm Dividend Rate:
200 days moving average:25.43
50 days moving average: 21.26
One day percent Change: -5.94



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,